Plain-English translation of NCT07020364 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing two different surgical approaches to treat benign prostatic hyperplasia — an enlarged prostate that causes urinary problems. Researchers want to see if a new single working element can safely and effectively perform surgery using either bipolar energy (similar to electrical cutting and sealing) or laser technology. This is an early feasibility study to make sure the new tool works well before it's used more broadly.
Enlarged prostate is very common in older men, but current surgical options have limitations. This trial exists to test whether a new, simplified surgical tool can make these procedures safer, more effective, and easier to perform.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive prostate surgery using one of two new techniques — either bipolar energy or laser — depending on which group you're assigned to. The surgical team will use the new single working element during your procedure to cut and seal tissue. You will likely have follow-up visits to check how well the surgery worked and to monitor for any side effects or complications.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt
Enrollment target
~60 participants
Started
October 2024
Primary completion
September 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
50 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mohamed K Omar, Assistant professor
Menoufia University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.